BG105602A - Il-5-inhibiting 6-azauracyl derivatives - Google Patents

Il-5-inhibiting 6-azauracyl derivatives

Info

Publication number
BG105602A
BG105602A BG105602A BG10560201A BG105602A BG 105602 A BG105602 A BG 105602A BG 105602 A BG105602 A BG 105602A BG 10560201 A BG10560201 A BG 10560201A BG 105602 A BG105602 A BG 105602A
Authority
BG
Bulgaria
Prior art keywords
6alkyl
4alkyl
optionally substituted
4alkylc
aryl
Prior art date
Application number
BG105602A
Other languages
Bulgarian (bg)
English (en)
Inventor
Eddy Jean Freyne
Frederik DEROOSE
Jean Fernand LACRAMPE
Werner EMBRECHTS
Jerome Michel FORTIN
Original Assignee
Janssen Pharmaceutica N.V.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica N.V. filed Critical Janssen Pharmaceutica N.V.
Publication of BG105602A publication Critical patent/BG105602A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D253/00Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00
    • C07D253/02Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00 not condensed with other rings
    • C07D253/061,2,4-Triazines
    • C07D253/0651,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members
    • C07D253/071,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members with hetero atoms, or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D253/075Two hetero atoms, in positions 3 and 5
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
BG105602A 1998-12-18 2001-06-14 Il-5-inhibiting 6-azauracyl derivatives BG105602A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP98204336 1998-12-18
PCT/EP1999/010169 WO2000037451A1 (en) 1998-12-18 1999-12-16 Il-5 inhibiting 6-azauracil derivatives

Publications (1)

Publication Number Publication Date
BG105602A true BG105602A (en) 2002-01-31

Family

ID=8234494

Family Applications (1)

Application Number Title Priority Date Filing Date
BG105602A BG105602A (en) 1998-12-18 2001-06-14 Il-5-inhibiting 6-azauracyl derivatives

Country Status (35)

Country Link
US (1) US6803364B1 (zh)
EP (1) EP1140873B1 (zh)
JP (1) JP2002533331A (zh)
KR (1) KR100635721B1 (zh)
CN (1) CN100343239C (zh)
AR (1) AR021887A1 (zh)
AT (1) ATE365723T1 (zh)
AU (1) AU773780B2 (zh)
BG (1) BG105602A (zh)
BR (1) BR9916366A (zh)
CA (1) CA2354511A1 (zh)
CO (1) CO5150147A1 (zh)
CZ (1) CZ20012062A3 (zh)
DE (1) DE69936396T2 (zh)
DK (1) DK1140873T3 (zh)
EA (1) EA004806B1 (zh)
EE (1) EE200100320A (zh)
ES (1) ES2289835T3 (zh)
HK (1) HK1042491A1 (zh)
HR (1) HRP20010455A2 (zh)
HU (1) HUP0104641A3 (zh)
ID (1) ID28880A (zh)
IL (1) IL143766A (zh)
MY (1) MY125808A (zh)
NO (1) NO319814B1 (zh)
NZ (1) NZ512748A (zh)
PL (1) PL198205B1 (zh)
PT (1) PT1140873E (zh)
SA (1) SA00201030B1 (zh)
SK (1) SK8152001A3 (zh)
TR (1) TR200101729T2 (zh)
TW (1) TWI249530B (zh)
UA (1) UA73107C2 (zh)
WO (1) WO2000037451A1 (zh)
ZA (1) ZA200104942B (zh)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8466096B2 (en) * 2007-04-26 2013-06-18 Afton Chemical Corporation 1,3,2-dioxaphosphorinane, 2-sulfide derivatives for use as anti-wear additives in lubricant compositions
RU2523651C2 (ru) * 2012-05-22 2014-07-20 Государственное бюджетное образовательное учреждение высшего профессионального образования "Владивостокский государственный медицинский университет" Министерства здравоохранения и социального развития Российской Федерации (ГБОУ ВПО ВГМУ Минздравсоцразвития России) Способ дифференцированного контроля базисного противовоспалительного лечения бронхиальной астмы у детей и подростков
RU2506045C1 (ru) * 2012-09-05 2014-02-10 Федеральное государственное бюджетное учреждение "Дальневосточный научный центр физиологии и патологии дыхания" Сибирского отделения РАМН Способ прогнозирования достижения контроля бронхиальной астмы

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2149645A1 (de) 1970-10-07 1972-09-14 Pfizer 2-Phenyl-as-triazin-3.5-(2H,4H)-dione und die Verwendung dieser Verbindungen zur Bekaempfung der Coccidiose
US3912723A (en) 1971-03-29 1975-10-14 Pfizer 2-Phenyl-as-triazine-3,5(2H,4H)diones
US3883528A (en) 1974-04-19 1975-05-13 Pfizer Preparation of 2(aryl)-as-triazine-3,5(2H,4H)-dione coccidiostats
US4631278A (en) 1984-08-01 1986-12-23 Janssen Pharmaceutica N.V. Anti-protozoal α-aryl-4-(4,5-dihydro-3,5-dioxo-1,2,4-triazin-2(3H)-yl)-benzeneacetonitrile derivatives, pharmaceutical compositions, and method of use therefor
CA1244024A (en) 1984-08-01 1988-11-01 Gustaaf M. Boeckx .alpha.- ARYL-4-(4,5-DIHYDRO-3,5-DIOXO-1,2,4-TRIAZIN- 2(3H)-YL)BENZENEACETONITRILES
GB8602342D0 (en) * 1986-01-30 1986-03-05 Janssen Pharmaceutica Nv 5 6-dihydro-2-(substituted phenyl)-1 2 4-triazine-3 5(2h 4h)-diones
CA1331757C (en) 1988-02-29 1994-08-30 Janssen Pharmaceutica Naamloze Vennootschap 5-lipoxygenase inhibiting 4-(4-phenyl-1-piperazinyl)phenols
EP0476439A1 (de) 1990-09-18 1992-03-25 Bayer Ag Substituierte 1,2,4-Triazindione, Verfahren zu ihrer Herstellung, Zwischenprodukte dafür und ihre Verwendung
DE4120138A1 (de) 1991-06-19 1992-12-24 Bayer Ag Substituierte hexahydro-1,2,4-triazindione, verfahren zu ihrer herstellung, zwischenprodukte dafuer und ihre verwendung
TW263495B (zh) 1992-12-23 1995-11-21 Celltech Ltd
GB9304920D0 (en) 1993-03-10 1993-04-28 Celltech Ltd Chemical compounds
RU2146674C1 (ru) 1993-10-15 2000-03-20 Такеда Кемикал Индастриз, Лтд. Производные триазина, способы их получения, антипротозойная композиция, добавка в пищу животных, способ ингибирования протозои у животных
TW332201B (en) 1995-04-06 1998-05-21 Janssen Pharmaceutica Nv 1,3-Dihydro-1-(phenylalkyl)-2H-imidazol-2-one derivatives
EP0737672B1 (en) 1995-04-14 2001-10-04 Takeda Schering-Plough Animal Health K.K. Method of producing triazine derivatives
DE69717380T2 (de) * 1996-08-30 2003-03-20 Takeda Schering Plough Animal 1,2,4-Triazin-3,5-Dionderivate als Anticoccidiosemittel
BR9811678A (pt) * 1997-07-10 2000-09-19 Janssen Pharmaceutica Nv Derivados de 6-azauracila de inibição de il-5
ID24224A (id) * 1997-07-10 2000-07-13 Janssen Pharmaceutica Nv Turunan-turunan 6-azaurasil sebagai inhibitor il-5

Also Published As

Publication number Publication date
CZ20012062A3 (cs) 2002-03-13
TWI249530B (en) 2006-02-21
NO319814B1 (no) 2005-09-19
MY125808A (en) 2006-08-30
HRP20010455A2 (en) 2002-06-30
ID28880A (id) 2001-07-12
AU773780B2 (en) 2004-06-03
EP1140873B1 (en) 2007-06-27
PT1140873E (pt) 2007-10-10
NZ512748A (en) 2004-05-28
PL198205B1 (pl) 2008-06-30
EE200100320A (et) 2002-10-15
CO5150147A1 (es) 2002-04-29
DK1140873T3 (da) 2007-10-15
BR9916366A (pt) 2001-09-18
NO20012987D0 (no) 2001-06-15
WO2000037451A1 (en) 2000-06-29
EP1140873A1 (en) 2001-10-10
EA200100677A1 (ru) 2001-12-24
IL143766A (en) 2005-11-20
KR20010080617A (ko) 2001-08-22
ZA200104942B (en) 2002-06-18
HUP0104641A3 (en) 2003-01-28
JP2002533331A (ja) 2002-10-08
IL143766A0 (en) 2002-04-21
AU2100100A (en) 2000-07-12
AR021887A1 (es) 2002-08-07
UA73107C2 (en) 2005-06-15
NO20012987L (no) 2001-08-17
HK1042491A1 (zh) 2002-08-16
DE69936396T2 (de) 2008-06-19
CN1330643A (zh) 2002-01-09
HUP0104641A2 (hu) 2002-04-29
TR200101729T2 (tr) 2001-10-22
DE69936396D1 (de) 2007-08-09
CA2354511A1 (en) 2000-06-29
KR100635721B1 (ko) 2006-10-17
EA004806B1 (ru) 2004-08-26
SK8152001A3 (en) 2002-04-04
SA00201030B1 (ar) 2006-10-11
ATE365723T1 (de) 2007-07-15
CN100343239C (zh) 2007-10-17
US6803364B1 (en) 2004-10-12
ES2289835T3 (es) 2008-02-01

Similar Documents

Publication Publication Date Title
BG104738A (en) Hiv inhibiting pyrimidine derivatives
NZ514095A (en) Amide compounds and medicinal use thereof
AP1475A (en) Trisubstituted 1, 3, 5-triazine derivatives for treatment of HIV infections.
NZ330118A (en) Thiophenopyrimidines, pharmaceutical compositions thereof and use in treating endocrine, psychiatric and neurologic conditions
TW200510431A (en) Quinazoline derivatives
HUT74367A (en) Fungicidal alpha-aryl-substituted cyclic amide derivatives, fungicid compositions containing these as active ingredients and using thereof
HK1016602A1 (en) Novel pyridonecarboxylic acid derivatives or their salts, and antibacterial agent comprising the same as the active ingredient
IL101785A0 (en) Urea derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
NZ239305A (en) 4-benzyl-5-substituted isoxazole derivatives, preparation and herbicidal compositions thereof
BG105571A (en) 4-(aminomethyl)-piperidine benzamides for treating gastrointestinal disorders
MXPA04002495A (es) Compuestos de imidazopiridin como moduladores del receptor 5-ht4.
NZ502180A (en) 6-Azauracil derivatives and their use as IL-5 inhibitors
BG105602A (en) Il-5-inhibiting 6-azauracyl derivatives
MY120046A (en) Angiogenesis inhibiting thiadiazolyl pyridazine derivatives.
BG106784A (en) 3-(4,5-dihydroisoxalole-5-yl)benzoylpyrazole
CA2352503A1 (en) Il-5 inhibiting 6-azauracil derivatives
CA2242494A1 (en) Novel n-substituted 4-((4'-aminobenzoyl)-oxymethyl)-piperidines having gastric prokinetic properties
ATE500231T1 (de) Hiv hemmende pyrimidin derivate
IL84874A (en) (((aminoalkyl)amino)-carbonyl)-di(het)areno-(b,e)(1,4)-diazepinones,their preparation and pharmaceutical compositions containing them
MY118312A (en) Angiogenesis inhibiting 5- substituted- 1,2,4- thiadiazolyl derivatives
ZA964100B (en) (2-morpholinymethyl)benzamide derivatives.
PL338009A1 (en) 2,4,4-three-substituted 1,3-dioxolane based antimycotic agents
NZ504299A (en) 1-aza-2-alkyl-6-aryl-cycloalkane compounds, a process for their preparation and pharmaceutical compositions containing them
KR950704331A (ko) 세펨 화합물 및 그의 약제학적 조성물(cephem compounds and their pharmaceutical compositions)
MY117552A (en) Novel esters of 3-hydroxy-piperidinemethanol derivatives